We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Identifies Hidden Heart Valve Defects from Patient’s ECG

By HospiMedica International staff writers
Posted on 08 Aug 2025

Heart valve diseases, affecting over 41 million people globally, can lead to heart failure, hospitalization, and even death. More...

Early diagnosis is critical, yet symptoms like shortness of breath or dizziness are often misattributed, and some patients show no signs until the disease is advanced. Subtle changes in heart function, especially in its electrical activity, often go undetected until it’s too late. Researchers have now created an artificial intelligence (AI) tool to identify risk much earlier, using just a standard electrocardiogram (ECG).

Developed by researchers at Imperial College London (London, UK), the AI model uses a patient’s ECG to predict the risk of developing regurgitant valvular heart diseases. These conditions, which affect the mitral, tricuspid, or aortic valves, involve blood leaking backwards through the heart. The AI detects early structural changes in the heart that are not apparent to doctors, making it possible to flag high-risk patients earlier than ever before physical symptoms or damage appear.

The research team trained the algorithm on nearly one million ECG and echocardiogram records from over 400,000 patients in China. To ensure accuracy across populations, the tool was then validated on over 34,000 patients in the US, showing that it works well across ethnically diverse populations and healthcare systems. The study, published in The European Heart Journal, shows that the AI model successfully predicted valve disease risk 69–79% of the time, showing reliable performance across diverse ethnic groups and healthcare settings.

Additionally, high-risk patients identified by the AI were up to 10 times more likely to develop valve leakage, offering a critical window for prevention. This technology could revolutionize care by identifying patients in need of monitoring or early intervention, long before heart valve disease causes harm. The research follows on from the team’s development of the related AI-ECG risk estimation model, known as AIRE, which can predict patients’ risk of developing and worsening disease from an ECG.

“Our work is harnessing AI to detect subtle changes at the earliest stage from a simple and common test, and we think this could be really transformative for doctors and patients,” said Dr. Arunashis Sau, one of the study leads. "Rather than waiting for symptoms or relying only on expensive and time-consuming imaging tests, we could use AI-enhanced ECGs to spot those most at risk earlier than ever before."


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Blood Gas Analyzer
i-Check200
Medical-Grade Display
HL2316SHTB
X-Ray Generator
Advantage Plus Generators
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Visual Abstract (Andrea Farolfi et al., Journal of Nuclear Medicine, 2026. DOI: 10.2967/jnumed.126.272108)

PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI

Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: WHX returns to Dubai Exhibition Centre, Expo City, and Dubai World Trade Centre from 5–28 January 2027 (Photo courtesy of World Health Expo)

World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition

World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000 professional visits, over 4,200 exhibitors and representatives from over... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.